Abstract:To explore the efficacy of Xiyanping combined with azithromycin sequential therapy in treating children with mycoplasma pneumoniae pneumonia(MPP)and its effect on micro-inflammatory state and immune indexes. Methods124 children with MPP were randomly divided into observation group and control group. The observation group was given Xiyanping combined with azithromycin sequential therapy, and the control group was given azithromycin sequential therapy. The efficacy in the two groups were compared, and the changes in microinflammatory status and immune indexes were observed before and after treatment. ResultsThe total effective rate of treatment in observation group was higher than that in the control group (P<0.05). After treatment, the levels ofperipheral blood CD4+, CD3+, CD4+/CD8+ and red blood cell-C3b receptor rate in the two groups were increased compared with those before treatment, and the levels in the observation group were higher than those in the control group (P<0.05). The levels of serum interleukin-6 (IL-6), IL-33, tumor necrosis factor (TNF-α), hypersensitive C-reactive protein (hs-CRP) and peripheral blood CD8+ and red blood cell immune complex rate were decreased compared with those before treatment, and the levels in observation group were lower than those in control group (P<0.05). ConclusionXiyanping combined with azithromycin sequential therapy has a good efficacy in the treatment of MPP, and it can significantly reduce theinflammatory response, and enhancecellular immunity level.